Related Experiment Video
Updated: Aug 13, 2026
06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
TEMPORARY REMOVAL: Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific
Marianna Fontana1, Scott D Solomon2, Philip N Hawkins1
1National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom.
Journal of the American College of Cardiology
|August 12, 2026
Summary
New therapies for transthyretin amyloid cardiomyopathy require a biological framework. We propose understanding disease progression through precursor protein biology, amyloid burden, and organ response for personalized treatment.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Biochemistry
Background:
- Transthyretin amyloid cardiomyopathy (ATTR-CM) treatment is advancing with novel therapies targeting specific disease mechanisms.
- Current disease progression monitoring relies on downstream clinical markers, not the targeted biological processes.
Purpose of the Study:
- To propose a biologically informed framework for understanding ATTR-CM progression and treatment response.
- To align disease biology with therapeutic mechanisms and monitoring strategies for personalized care.
Main Methods:
- Conceptual framework development based on distinct yet interconnected biological domains.
- Analysis of the interplay between precursor protein biology, amyloid burden, and organ response.
Main Results:
- Disease progression in ATTR-CM is conceptualized as the interaction of three domains: precursor protein biology, amyloid burden, and organ response.
- These domains influence each other but may evolve and respond to therapy independently.
Conclusions:
- A biologically informed framework is crucial for mechanism-specific ATTR-CM therapies.
- Future monitoring should focus on biomarkers quantifying precursor protein biology, amyloid burden, and organ response for precision guidance.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...